221 related articles for article (PubMed ID: 9193800)
21. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
[TBL] [Abstract][Full Text] [Related]
22. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector.
Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E
Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446
[TBL] [Abstract][Full Text] [Related]
23. [Regulatory mechanism of HIV gene expression].
Hatanaka M
Nihon Rinsho; 1993 Sep; 51 Suppl():43-57. PubMed ID: 8271415
[No Abstract] [Full Text] [Related]
24. Human immunodeficiency virus-1 tat- and tat/nef-defective genomes containing HIV-regulated diphtheria toxin A chain gene inhibit HIV replication.
Brdar B; Matulić M; Rubelj I; Ivanković M; Reich E
Croat Med J; 2002 Oct; 43(5):591-7. PubMed ID: 12402403
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
26. Helper plasmids for production of HIV-1-derived vectors.
Fuller M; Anson DS
Hum Gene Ther; 2001 Nov; 12(17):2081-93. PubMed ID: 11747598
[TBL] [Abstract][Full Text] [Related]
27. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
Chen P; Hübner W; Riviere K; Liu YX; Chen BK
Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
[TBL] [Abstract][Full Text] [Related]
28. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
[TBL] [Abstract][Full Text] [Related]
29. Requirement of an additional Sam68 domain for inhibition of human immunodeficiency virus type 1 replication by Sam68 dominant negative mutants lacking the nuclear localization signal.
Zhang J; Liu Y; Henao J; Rugeles MT; Li J; Chen T; He JJ
Gene; 2005 Dec; 363():67-76. PubMed ID: 16236470
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
31. Tat and Rev: positive regulators of HIV gene expression.
Rosen CA; Pavlakis GN
AIDS; 1990 Jun; 4(6):499-509. PubMed ID: 2201316
[No Abstract] [Full Text] [Related]
32. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells.
Harrison GS; Maxwell F; Long CJ; Rosen CA; Glode LM; Maxwell IH
Hum Gene Ther; 1991; 2(1):53-60. PubMed ID: 1863640
[TBL] [Abstract][Full Text] [Related]
33. The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance.
Liem SE; Ramezani A; Li X; Joshi S
Hum Gene Ther; 1993 Oct; 4(5):625-34. PubMed ID: 8280800
[TBL] [Abstract][Full Text] [Related]
34. Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.
Lassen KG; Ramyar KX; Bailey JR; Zhou Y; Siliciano RF
PLoS Pathog; 2006 Jul; 2(7):e68. PubMed ID: 16839202
[TBL] [Abstract][Full Text] [Related]
35. The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.
Srinivasakumar N; Chazal N; Helga-Maria C; Prasad S; Hammarskjöld ML; Rekosh D
J Virol; 1997 Aug; 71(8):5841-8. PubMed ID: 9223473
[TBL] [Abstract][Full Text] [Related]
36. PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression.
Zolotukhin AS; Michalowski D; Bear J; Smulevitch SV; Traish AM; Peng R; Patton J; Shatsky IN; Felber BK
Mol Cell Biol; 2003 Sep; 23(18):6618-30. PubMed ID: 12944487
[TBL] [Abstract][Full Text] [Related]
37. Diminished production of human immunodeficiency virus type 1 in astrocytes results from inefficient translation of gag, env, and nef mRNAs despite efficient expression of Tat and Rev.
Gorry PR; Howard JL; Churchill MJ; Anderson JL; Cunningham A; Adrian D; McPhee DA; Purcell DF
J Virol; 1999 Jan; 73(1):352-61. PubMed ID: 9847339
[TBL] [Abstract][Full Text] [Related]
38. [Proliferative mechanism and control of AIDS virus].
Okamoto H
Nihon Rinsho Meneki Gakkai Kaishi; 1996 Dec; 19(6):548-51. PubMed ID: 9081714
[No Abstract] [Full Text] [Related]
39. Regulatory genes of human immunodeficiency viruses.
Wong-Staal F; Haseltine WA
Mol Genet Med; 1992; 2():189-219. PubMed ID: 1458225
[No Abstract] [Full Text] [Related]
40. A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent.
Bray M; Prasad S; Dubay JW; Hunter E; Jeang KT; Rekosh D; Hammarskjöld ML
Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1256-60. PubMed ID: 8108397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
